Ketoprofen in the cat: Pharmacodynamics and chiral pharmacokinetics

Veterinary Journal

Volumn 165, Issue 1, 2003, Pages 21-35

  Lees, P ^a   Taylor, P M ^b   Landoni, F M ^a   Arifah, A K ^a   Waters, C ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cat; Chirality; Enantiomers; Ketoprofen; Pharmacodynamics; Pharmacokinetics

Indexed keywords

CARRAGEENAN; CYCLOOXYGENASE 1; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; THROMBOXANE B2;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CAT; CHIRALITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; ENANTIOSELECTIVITY; ENZYME INHIBITION; FEMALE; INFLAMMATION; MALE; MEAN RESIDENCE TIME; NONHUMAN; RACEMIC MIXTURE; SKIN TEMPERATURE; STATISTICAL SIGNIFICANCE; URTICARIA; ANIMAL; BLOOD; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; SPECIES DIFFERENCE; STEREOISOMERISM;

FELIS CATUS;

ADMINISTRATION, ORAL; ANIMALS; CARRAGEENAN; CATS; CROSS-OVER STUDIES; FEMALE; INFLAMMATION; INJECTIONS, INTRAVENOUS; KETOPROFEN; MALE; SKIN TEMPERATURE; SPECIES SPECIFICITY; STEREOISOMERISM;

EID: 0038657740     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-0233(02)00168-5     Document Type: Article

References (49)

1. Abas A. Meffin P.J. Enantioselective disposition of 2-arylpropionic acid non-steroidal anti-inflammatory drugs. IV. Ketoprofen disposition Journal of Pharmacology and Experimental Therapeutics 240 1987 637-641
2. Alkatheeri N.A. Wasfi L.A. Lambert M. Pharmacokinetics and metabolism of ketoprofen after intravenous and intramuscular administration in camels Journal of Veterinary Pharmacology and Therapeutics 22 1999 127-135
3. Ariens E.J. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology European Journal of Clinical Pharmacology 26 1984 663-668
4. Arifah A.K. Landoni M.F. Frean S.P. Lees P. Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep American Journal of Veterinary Research 62 2001 77-86
5. Brideau C. Van Staden C. Chan C.C. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs and cats American Journal of Veterinary Research 62 2001 1755-1760
6. Brink P. Degraves F. Ravis W.R. Johansen D. Campbell J.D. Duran S.H. Stereospecific pharmacokinetics of free and protein-bound ketoprofen in serum and synovial fluid of horses after intravenous and intramuscular administration American Journal of Veterinary Research 59 1998 739-743
7. Caldwell J. Hutt A.J. Fournel-Gigleux S. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences Biochemical Pharmacology 37 1988 105-114
8. Campbell D.B. Stereoselectivity in clinical pharmacokinetics and drug development European Journal of Drug Metabolism and Pharmacokinetics 15 1990 109-125
9. Castro E. Soraci A. Fogel F. Tapia O. Chiral inversion of R(-) fenoprofen and ketoprofen enantiomers in cats Journal of Veterinary Pharmacology and Therapeutics 23 2000 265-271
10. Delatour P. Benoit E. Bourdin M. Gobron M. Moysan F. Enantioselectivite comparee de la disposition de deux anti-inflammatoires nonsteroidiens, le ketoprofene et le carprofene, chez 1'homme et 1'animal Bulletin Academie Nationale Medicine 177 1993 515-527
11. Delatour P. Benoit E. Besse S. Soraci A. Asymetrie moleculaire et pharmacologie comparee Revue Medicale Veterinaire 145 1994 551-561
12. Evans A.M. Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs European Journal of Clinical Pharmacology 42 1992 237-256
13. Foster R.T. Jamali F. High-performance liquid chromatographic assay of ketoprofen enantiomers in human plasma and urine Journal of Chromatography 416 1987 388-393
14. Foster R.T. Jamali F. Stereoselective pharmacokinetics of ketoprofen in the rat Drug Metabolism and Disposition 16 1988 623-626
15. Fu J.Y. Masferrer J.L. Seibert K. Raz A. Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes Journal of Biological Chemistry 265 1990 16737-16740
16. Fuder H. Stiegler S. Wetzelsberger N. Wieckhorst G. Lange R. Lucker P.W. Effect of buffering on pharmacokinetics of ketoprofen enantiomers in man British Journal of Clinical Pharmacology 44 1997 527-530
17. Geisslinger G. Menzel S. Wissel K. Brune K. Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate British Journal of Clinical Pharmacology 40 1995 73-75
18. Glew A. Aviad A.D. Keister M. Meo N.J. Use of ketoprofen as an antipyretic in cats Canadian Veterinary Journal 37 1996 222-225
19. Hayball P.J. Nation R.L. Bochner F. Enantioselective pharmacodynamics of the nonsteroidal antiinflammatory drug ketoprofen: in vitro inhibition of human platelet cyclooxygenase activity Chirality 4 1992 484-487
20. Hayball P.J. Nation R.L. Bochner F. Sansom L.N. Ahern M.J. Smith M.D. The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis British Journal of Clinical Pharmacology 36 1993 185-193
21. Higgins A.J. Lees P. Arachidonic acid metabolites in carrageenin-induced equine inflammatory exudate Journal of Veterinary Pharmacology and Therapeutics 7 1984 65-72
22. Hutt A.J. Caldwell J. The metabolic chiral inversion of 2-arylpropionic acids-a novel route with pharmacological consequences Journal of Pharmacy and Pharmacology 35 1983 693-704
23. Jamali F. Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs European Journal of Drug Metabolism and Pharmacokinetics 13 1988 1-9
24. Jaussaud P. Bellon C. Besse S. Courtot D. Delatour P. Enantioselective pharmacokinetics of ketoprofen in horses Journal of Veterinary Pharmacology and Therapeutics 16 1993 373-376
25. Kadir, A. A. (1998). Pharmacodynamic and pharmacokinetic studies on ketoprofen and phenylbutazone. PhD Thesis. University of London
26. Kujuba D.A. Fletcher B.S. Varnum B.C. Lim R.W. Herschman H. TLS10 a phorbal ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue Journal of Biological Chemistry 266 1991 12866-12872
27. Landoni M.F. Lees P. Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves Chirality 7 1995 586-597
28. Landoni M.F. Lees P. Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling Equine Veterinary Journal 27 1995 247-256
29. Landoni M.F. Lees P. Influence of formulation on the pharmacokinetics and bioavailability of racemic ketoprofen in horses Journal of Veterinary Pharmacology and Therapeutics 18 1995 446-450
30. Landoni M.F. Lees P. Chirality: a major issue in veterinary pharmacology Journal of Veterinary Pharmacology and Therapeutics 19 1996 82-84
31. Landoni M.F. Lees P. Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in the horse Journal of Veterinary Pharmacology and Therapeutics 19 1996 466-474
32. Landoni M.F. Cunningham P.M. Lees P. Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling Journal of Veterinary Pharmacology and Therapeutics 18 1995 315-324
33. Landoni M.F. Foot R. Frean S. Lees P. Effects of flunixin, tolfenamic acid, R(-) and S(+) ketoprofen on the response of equine synoviocytes to lipopolysaccharide stimulation Equine Veterinary Journal 28 1996 468-475
34. Landoni M.F. Soraci A.L. Delatour P. Lees P. Enantioselective behaviour of drugs used in domestic animals: a review Journal of Veterinary Pharmacology and Therapeutics 20 1997 1-16
35. Landoni M.F. Comas W. Mucci N. Anglarilli G. Bidal D. Lees P. Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep Journal of Veterinary Pharmacology and Therapeutics 22 1999 349-359
36. Lees P. Ayliffe T. Maitho T.E. Taylor J.B.O. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration Research in Veterinary Science 44 1988 57-67
37. Lees P. Mckellar Q.A. Foot R. Gettinby G. Pharmacodynamics and pharmacokinetics of tolfenamic acid in ruminating calves: evaluation in models of acute inflammation The Veterinary Journal 155 1998 275-288
38. Maitho T.E. Lees P. Taylor J.B. Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies Journal of Veterinary Pharmacology and Therapeutics 9 1986 26-39
39. Mauleon D. Mis R. Ginesta J. Ortega E. Vilageliu J. Basi N. Carganico G. Pharmacokinetics of ketoprofen enantiomers in monkeys following single and multiple oral administration Chirality 6 1994 537-542
40. Ricketts A.P. Lundy K.M. Seibel S.B. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs American Journal of Veterinary Research 59 1998 1441-1446
41. Sallustio B.C. Purdie Y.J. Whitehead A.G. Ahern M.J. Meffin P.J. The disposition of ketoprofen enantiorners in man British Journal of Clinical Pharmacology 26 1988 765-770
42. Sams R. Gerken D.F. Ashcraft S.M. Pharmacokinetics of ketoprofen after multiple intravenous doses to mares Journal of Veterinary Pharmacology and Therapeutics 18 1995 108-116
43. Schmitt M. Guentert T.W. Biopharmaceutical evaluation of ketoprofen following intravenous, oral and rectal administration in dogs Journal of Pharmaceutical Sciences 79 1990 614-616
44. Skeith K.J. Dasgupta M. Lange R. Jamali F. The influence of renal function on the pharmacokinetics of unchanged and acyl-glucuroconjugated ketoprofen enantiomers after 50 and 100 mg racemic ketoprofen British Journal of Clinical Pharmacology 42 1996 163-169
45. Suesa N. Fernandez M.F. Gutierrez M. Rufat K.J. Rotllan E. Calvo L. Mauleon D. Carganico G. Stereoselective cyclooxygenase inhibition in cellular models by the enantiomers of ketoprofen Chirality 5 1993 589-595
46. Taylor P.M. Delatour P. Landoni F.M. Deal C. Pickett C. Shojaee Aliabadi F. Foot R. Lees P. Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat Research in Veterinary Science 60 1996 144-151
47. Toutain P.L. Autefage A. Legrand C. Alvinerie M. Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling Journal of Veterinary Pharmacology and Therapeutics 17 1994 459-469
48. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs Nature 231 1971 232-235
49. Warner T.D. Giuliano F. Vojnovic I. Bukasa A. Mitchell J.A. Vane J.R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis Proceedings of National Academy of Sciences 96 1999 7563-7568